X-70424993-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017711.4(GDPD2):c.9G>T(p.Glu3Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000381 in 1,077,201 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E3K) has been classified as Uncertain significance.
Frequency
Consequence
NM_017711.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDPD2 | ENST00000374382.4 | c.9G>T | p.Glu3Asp | missense_variant | Exon 2 of 16 | 1 | NM_017711.4 | ENSP00000363503.3 | ||
GDPD2 | ENST00000453994.6 | c.9G>T | p.Glu3Asp | missense_variant | Exon 2 of 17 | 2 | ENSP00000414019.2 | |||
GDPD2 | ENST00000536730.5 | c.-132-361G>T | intron_variant | Intron 1 of 14 | 2 | ENSP00000445982.1 | ||||
GDPD2 | ENST00000538649.5 | c.-28-770G>T | intron_variant | Intron 1 of 13 | 2 | ENSP00000444601.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.000101 AC: 15AN: 148027Hom.: 0 AF XY: 0.000203 AC XY: 9AN XY: 44339
GnomAD4 exome AF: 0.0000381 AC: 41AN: 1077201Hom.: 0 Cov.: 29 AF XY: 0.0000774 AC XY: 27AN XY: 348755
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.9G>T (p.E3D) alteration is located in exon 2 (coding exon 1) of the GDPD2 gene. This alteration results from a G to T substitution at nucleotide position 9, causing the glutamic acid (E) at amino acid position 3 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at